Sponsor or institution
Clinical trials and research at Inhalon Biopharma, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Inhaled muco-trapping antibody therapy for RSV (IN-002)
This project tests an inhaled antibody called IN-002 that aims to trap and clear RSV from the airways to help infants, children, and adults at risk of severe RSV.
-
Developing an inhaled antibody therapy for a common respiratory virus in children
This study is testing a new inhaled treatment for young children with human metapneumovirus (MPV), a common cause of respiratory infections, to see if delivering a special medicine directly to their lungs can help them feel better faster.
-
Developing an inhaled antibody therapy for Respiratory Syncytial Virus (RSV)
This study is testing a new inhaled treatment called IN-002 for Respiratory Syncytial Virus (RSV) to help infants, young children, and vulnerable adults breathe easier at home and avoid hospital visits.
-
Developing an inhaled treatment for COVID-19 and similar infections
This study is testing a new inhaled treatment for COVID-19 that uses special antibodies to help trap and remove the virus from your airways, making it easier for you to use at home and potentially keeping you out of the hospital.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.